Subsequent analysis of this sample showed ROS1 expression to be 50-fold higher than the median of all sarcoma samples, supporting the existence of a promoter fusion that deregulated ROS1 expression (Supplementary Fig. 10a, b). This evidence concerns the gene ROS1 and sarcoma.